Skip to main content
Equibles

4574 · TAIKO PHARMACEUTICAL CO., LTD. · Financials

Use 4574 with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research 4574.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
265 JPY +6 (+2.32%) At close · Nov 12
Rebalance outlook locked
Market Cap
13.33B JPY
Shares
50.31M
Volume · Nov 12 46.5K Avg daily vol (3M) 115.31K

Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.

Pull these statements through the financial statements API or MCP →
Revenue
6.4B +1.7%
FY2025 Revenue FY2021–FY2025
Net Income
923M +2.8%
FY2025 Net Income FY2021–FY2025
Gross Margin
54.42% -3.8pp
FY2025 Gross Margin FY2021–FY2025
Operating Margin
7.18% -2.8pp
FY2025 Operating Margin FY2021–FY2025
Operating Cash Flow
814M +124.9%
FY2025 Operating Cash Flow FY2021–FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Income Statement Balance Sheet Cash Flow All Metrics
Annual Quarterly
Line Item FY2025 FY2024 FY2023 FY2022 FY2021
JPY 6.4B 6.29B 6.12B 5.04B 11.3B
JPY 2.92B 2.63B 3.54B 3.96B 7.97B
JPY 3.48B 3.67B 2.58B 1.08B 3.33B
JPY 459M 629M -1.01B -3.08B -4.95B
JPY 958M 565M -3.56B -4.87B -8.89B
JPY 34M -332M 47M 25M 706M
JPY 923M 898M -3.61B -4.9B -9.59B
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Capital Returned to Shareholders

Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2021–FY2024: 784M in dividends.

Debt Profile

No verified debt profile is available yet. This does not establish that the company has no debt or covenants.